A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 52, Issue 4, 2012, Pages 321-326

  Cook, Timothy J ^a   Qiu, Charles C ^a   Dickinson, Jan E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

alloimmune thrombocytopenia; antigen; fetal and neonatal alloimmune thrombocytopenia; fetus; newborn; platelet

Indexed keywords

IMMUNOGLOBULIN; PREDNISOLONE; THROMBOCYTE ANTIGEN;

ADJUVANT THERAPY; ADULT; AUSTRALIA; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FETUS DEATH; GESTATIONAL AGE; HUMAN; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; OBSTETRICS; OUTCOME ASSESSMENT; PERINATAL PERIOD; POSTNATAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TERTIARY HEALTH CARE; THROMBOCYTE TRANSFUSION;

ADULT; FEMALE; FETAL DISEASES; FETUS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; PLATELET COUNT; PLATELET TRANSFUSION; PREDNISOLONE; PREGNANCY; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; THROMBOCYTOPENIA; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE; WESTERN AUSTRALIA;

EID: 84864714158     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2012.01438.x     Document Type: Review

References (23)

1. Spencer JA, Burrows RF,. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001; 41 (1): 45-55.
2. Mueller-Eckhardt C, Kiefel V, Grubert V, et al,. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; 333 (8634): 363-366.
3. Davoren A, Curtis BR, Aster RH, McFarland JG,. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004; 44 (8): 1220-1225.
4. Kaplan C,. Platelet alloimmunity: the fetal/neonatal alloimmune thrombocytopenia. Vox Sang 2002; 83 (S1): 289-291.
5. Kamphuis MM, Paridaans N, Porcelijn L, et al,. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: a systematic review. BJOG 2010; 117 (11): 1335-1343.
6. Kamphuis MM, Oepkes D,. Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions. Prenat Diagn 2011; 3197: 712-719.
7. Dickinson JE,. Fetomaternal alloimmune thrombocytopenia: increasing awareness. Aust N Z J Obstet Gynaecol 2011; 51 (3): 189-190.
8. Williamson LM, Hackett G, Rennie J, et al,. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PIA1, Zwa) as determined by antenatal screening. Blood 1998; 92 (7): 2280-2287.
9. Turner ML, Bessos H, Fagge T, et al,. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005; 45 (12): 1945-1956.
10. Knight M, Pierce M, Allen D, et al,. The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources. Br J Haematol 2011; 152 (4): 460-468.
11. Kjeldsen-Kragh J, Killie MK, Tomter G, et al,. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007; 110 (3): 833-839.
12. Kanhai HH, Porcelijn L, Engelfriet CP, et al,. Management of alloimmune thrombocytopenia. Vox Sang 2007; 93 (4): 370-385.
13. Bussel JB, Berkowitz RL, McFarland JG, et al,. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988; 319 (21): 1374-1378.
14. Ni H, Chen P, Spring CM, et al,. A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood 2006; 107 (7): 2976-2983.
15. Paridaans N, Wikman A, Kamphuis M, et al,. IVIG to prevent fetal intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia (FNAIT): can we reduce the dose to 0.5g/kg/wk? Am J Obstet Gynecol 2011; 204 (1): S32-S33.
16. Bussel JB, Primiani A,. Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates. Blood Rev 2008; 22 (1): 33-52.
17. Nicolini U, Tannirandorn Y, Gonzalez P, et al,. Continuing controversy in alloimmune thrombocytopenia: fetal hyperimmunoglobulinemia fails to prevent thrombocytopenia. Am J Obstet Gynecol 1990; 163 (4 pt 1): 1144-1146.
18. Berkowitz RL, Kolb EA, McFarland JG, et al,. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 2006; 107 (1): 91-96.
19. Overton TG, Duncan KR, Jolly M, et al,. Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome. Am J Obstet Gynecol 2002; 186 (4): 826-831.
20. Ghevaert C, Campbell K, Walton J, et al,. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Transfusion 2007; 47 (5): 901-910.
21. Rayment R, Brunskill SJ, Soothill PW, et al,. Antenatal interventions for fetomaternal alloimmune thrombocytopenia (Review). Cochrane Database Syst Rev 2011; 5: Art. No.: CD004226. DOI: 10.1002/14651858.CD004226.pub3.
22. Van den Akker ESA, Oepkes D, Brand A, Kanhai HHH,. Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia? BJOG 2006; 113: 781-783.
23. McQuilten ZK, Wood EM, Savoia H, Cole S,. A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT Registry. Aust N Z J Obstet Gynaecol 2011; 51 (3): 191-198.